Suppr超能文献

微小RNA-590通过靶向ADAM9抑制非小细胞肺癌细胞的肿瘤发生和侵袭性。

microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.

作者信息

Wang Fei-Fei, Wang Song, Xue Wen-Hua, Cheng Jing-Liang

机构信息

Department of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

出版信息

Mol Cell Biochem. 2016 Dec;423(1-2):29-37. doi: 10.1007/s11010-016-2822-y. Epub 2016 Oct 21.

Abstract

microRNAs (miRNAs), a family of small non-coding RNA molecules, are implicated in cancer growth and progression. In the present study, we examined the expression and biological roles of miR-590 in non-small cell lung cancer (NSCLC). Compared to normal lung tissues, miR-590 expression was downregulated in primary NSCLCs and, to a greater extent, in corresponding brain metastases. NSCLC cell lines with high metastatic potential had significantly (P < 0.05) lower levels of miR-590 than those with low metastatic potential. Re-expression of miR-590 suppressed NSCLC cell proliferation, colony formation, migration, and invasion in vitro and tumorigenesis in vivo. In contrast, inhibition of miR-590 enhanced the migration and invasion of NSCLC cells. Mechanistic studies revealed that a disintegrin and metalloproteinase 9 (ADAM9) was a direct target of miR-590. Delivery of miR-590 mimic was found to decrease endogenous ADAM9 expression in NSCLC cells. Enforced expression of a miRNA-resistant form of ADAM9 significantly restored the aggressive behaviors in miR-590-overexpressing NSCLC cells. Taken together, our data reveal miR-590 as a tumor suppressor in NSCLC, which is at least partially mediated through targeting of ADAM9. Restoration of miR-590 may provide a promising therapeutic strategy for NSCLC.

摘要

微小RNA(miRNA)是一类小的非编码RNA分子,与癌症的生长和进展有关。在本研究中,我们检测了miR-590在非小细胞肺癌(NSCLC)中的表达及生物学作用。与正常肺组织相比,miR-590在原发性NSCLC中表达下调,在相应的脑转移瘤中下调程度更大。具有高转移潜能的NSCLC细胞系中miR-590水平显著(P<0.05)低于低转移潜能的细胞系。miR-590的重新表达在体外抑制了NSCLC细胞的增殖、集落形成、迁移和侵袭以及体内肿瘤发生。相反,抑制miR-590增强了NSCLC细胞的迁移和侵袭。机制研究表明,解整合素和金属蛋白酶9(ADAM9)是miR-590的直接靶点。发现递送miR-590模拟物可降低NSCLC细胞中内源性ADAM9的表达。强制表达抗miRNA形式的ADAM9可显著恢复miR-590过表达的NSCLC细胞的侵袭性行为。综上所述,我们的数据揭示miR-590是NSCLC中的一种肿瘤抑制因子,其至少部分是通过靶向ADAM9介导的。恢复miR-590可能为NSCLC提供一种有前景的治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验